AI in Healthcare and Life Sciences Podcast

Emerj Technology Research
  • 3.8 (4)
  • BUSINESS
  • UPDATED WEEKLY
AI in Healthcare and Life Sciences Podcast

The AI in Healthcare and Life Sciences is for non-technical leaders interested in where AI is creating an impact for patients, for business workflows, and for the bottom line. Global Fortune 500 healthcare and life sciences leaders join Emerj AI Research team (and CEO Daniel Faggella) to share where they’re seeing AI impact today, as well as best-practices for AI adoption and ROI measurement in healthcare and pharma. Visit our advertising page to learn more about reaching our executive audience of AI adopters in the world’s largest banking and insurance firms: https://emerj.com/advertise

  1. Breaking Down Regulatory Barriers in Pharma with AI and Automation - with Fred Manby of Iambic Therapeutics

    MAR 6

    Breaking Down Regulatory Barriers in Pharma with AI and Automation - with Fred Manby of Iambic Therapeutics

    Today’s guest is Fred Manby, CTO and Co-founder of Iambic Therapeutics. Iambic uses algorithms to drive a high-throughput experimental platform that specializes in developing new drug discovery techniques. Fred returns to the program to explore the next frontier of AI-driven drug discovery. Building on the previous discussion, this episode delves into the transformative role of automation, data generation, and predictive modeling in pharmaceutical development. This episode is sponsored by Iambic Therapeutics. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.

    20 min
  2. Optimizing Drug Development Pipelines with Machine Learning- with Fred Manby of Iambic Therapeutics

    FEB 6

    Optimizing Drug Development Pipelines with Machine Learning- with Fred Manby of Iambic Therapeutics

    Today’s guest is Fred Manby, CTO and Co-founder of Iambic Therapeutics. Iambic uses algorithms to drive a high-throughput experimental platform that specializes in developing new drug discovery techniques. Fred joins us on today’s program to discuss the evolving landscape of drug discovery in life sciences. With AI playing an increasingly critical role, the conversation explores the biggest challenges facing drug discovery workflows and how life sciences leaders can better leverage data-driven tools to address them. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    19 min
  3. Driving Drug Targeting Efficiencies with LLMs and GenAI - with Ben Coverdale of Patsnap

    JAN 2

    Driving Drug Targeting Efficiencies with LLMs and GenAI - with Ben Coverdale of Patsnap

    Today’s guest is Ben Coverdale, Global Account Director of Life Sciences at Patsnap. Patsnap is a healthcare technology company that provides IP and R&D teams with enhanced insights to make informed and timely decisions. Using a specialized AI model and the Hiro assistant, the platform boosts productivity and reduces inefficiencies across the innovation lifecycle. Ben returns to the show to dive deeper into the real-world applications of generative AI and large language models (LLMs) that are reshaping the drug discovery landscape. He provides a closer look at use cases where AI is not just enhancing traditional processes but enabling entirely new possibilities in drug targeting and sequencing that were previously unimaginable. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    21 min
  4. GenAI and LLM Applications in Life Sciences - with Ben Coverdale of Patsnap

    12/05/2024

    GenAI and LLM Applications in Life Sciences - with Ben Coverdale of Patsnap

    Today’s guest is Ben Coverdale, Global Account Director of Life Sciences at Patsnap. Patsnap is a healthcare technology company that provides IP and R&D teams with enhanced insights to make informed and timely decisions. Using a specialized AI model and the Hiro assistant, the platform boosts productivity and reduces inefficiencies across the innovation lifecycle. Ben joins us on today’s program to explore the transformative role of generative AI and large language models (LLMs) in life sciences. His discussion with Emerj Senior Editor Matthew DeMello covers how data silos are dissolving as companies adopt integrated LLM strategies, offering new possibilities for collaboration and efficiency. Ben provides insight into the practical applications of LLMs, the promise they hold for optimizing R&D, and the potential impact on the regulatory landscape. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    18 min

  5. 11/07/2024

    Solving the Go-to-Market Inefficiencies of Life Sciences - with Rajvir Madan of Arcutis Biotherapeutics

    Today’s guest is Rajvir Madan, Chief Digital and Information Technology Officer at Arcutis Biotherapeutics. Arcutis Biotherapeutics is a biopharmaceutical company that develops therapies for skin-related conditions. Rajvir joins us on today’s show to explore the pressing challenges and exciting opportunities within the life sciences industry. From long development timelines to the complexities of regulatory submissions, Rajvir highlights why the traditional approach to bringing new treatments to market—often spanning over a decade—needs urgent rethinking. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    26 min

  6. 10/03/2024

    Driving Data Efficiencies in Healthcare - with RJ Kedziora of Estenda Solutions

    Today’s guest is RJ Kedziora, Co-founder, Partner, Chief Operating Officer, and Chief Technology Officer at Estenda Solutions. Estenda is a healthcare and medical custom software development, data analytics, and consulting company with 20 years of experience in digital health. RJ joins us on today’s episode to explore where the industry is seeing use cases for leveraging new AI capabilities to help drive data efficiencies. Once these technologies are commonplace, RJ shares what he thinks the future of data in healthcare spaces is going to look like. To discover more AI use cases, best practice guides, white papers, frameworks, and more, join Emerj Plus at emerj.com/p1.

    15 min

  7. 09/05/2024

    Leveraging Data in Healthcare Organizations - with RJ Kedziora of Estenda Solutions

    Today’s guest is RJ Kedziora, Co-founder, Partner, and Chief Operating and Technology Officer at Estenda Solutions. Estenda is a healthcare and medical custom software development, data analytics, and consulting company with 20 years of experience in digital health. RJ joins us on today’s program to talk about challenges for healthcare leaders in driving the data necessary to take advantage of these new use cases in generative AI and beyond. Throughout the episode, RJ provides measured and tested frameworks for tackling new opportunities in the standardization and interoperability of healthcare systems, especially where they intersect with the need for data sharing across the sector and what that means for HIPAA protections. To access Emerj’s frameworks for AI readiness, ROI, and strategy, visit Emerj Plus at emerj.com/p1.

    27 min

  8. 08/08/2024

    Driving Patient Experiences Through Data Science-Driven Approaches to Infrastructure - with Xiong Liu of Novartis

    Today’s guest is Xiong Liu, Director of Data Science and AI at Novartis. Xiong joins us on the program today to offer life sciences leaders a framework for driving meaningful data infrastructure advancements at their organizations. Xiong emphasizes the need for robust data quality, ethics considerations, and scalability to ensure practical applications in real-life use cases. Later, he highlights the importance of understanding customer perspectives, aligning business goals with AI efforts, and leveraging graph databases to manage large-scale healthcare data. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

    18 min
See All (15)

    Ratings & Reviews

    3.8
    out of 5
    4 Ratings

    About

    The AI in Healthcare and Life Sciences is for non-technical leaders interested in where AI is creating an impact for patients, for business workflows, and for the bottom line. Global Fortune 500 healthcare and life sciences leaders join Emerj AI Research team (and CEO Daniel Faggella) to share where they’re seeing AI impact today, as well as best-practices for AI adoption and ROI measurement in healthcare and pharma. Visit our advertising page to learn more about reaching our executive audience of AI adopters in the world’s largest banking and insurance firms: https://emerj.com/advertise

    Information

    You Might Also Like

    Content Restricted

    This episode can’t be played on the web in your country or region.

    To listen to explicit episodes, sign in.

    Stay up to date with this show

    Sign in or sign up to follow shows, save episodes, and get the latest updates.
    Select a country or region

    Africa, Middle East, and India

    Asia Pacific

    Europe

    Latin America and the Caribbean

    The United States and Canada